微塑料:一种可修改的心脏风险因素
Michael Kaiser1, Elena Tran1, Manish A Parikh1,2
1From the Department of Medicine, New York Presbyterian Brooklyn Methodist Hospital, Brooklyn, NY.
Cardiology in review
|January 13, 2026
概括
微塑料暴露与心血管疾病有关,可能增加心脏病发作,中风和死亡的风险. 识别和减轻微塑料可能提供一种减少心血管疾病风险的新方法.
科学领域:
- 环境科学 环境科学
- 心脏病学 心脏病学
- 毒理学 毒理学 毒理学
背景情况:
- 心血管疾病是全球主要的死亡原因.
- 传统的风险因素并不能捕捉到所有有助于因素.
- 微塑料污染是一个日益严重的环境问题.
研究的目的:
- 审查有关微塑料暴露的文献.
- 讨论微塑料对心血管疾病的临床影响.
主要方法:
- 实验和临床研究的文献综述.
- 对微塑料对心血管健康标志物影响的分析.
主要成果:
- 微塑料诱导氧化应激,炎症和心脏毒性.
- 在人类的冠状动脉和动脉斑块中发现了微塑料.
- 患有心血管斑块中的微塑料的患者,患有主要心血管不良事件的风险增加了4.5倍.
结论:
- 微塑料暴露与心血管疾病有关.
- 微塑料是心血管疾病的潜在可改变的风险因素.
- 需要进一步的研究来了解完整的临床影响.
关键词:
在 NF-kBB 中.ангиотензин II 的使用动脉样硬化 动脉样硬化心血管疾病心血管疾病内皮质功能障碍 在内皮质功能障碍环境心脏病学环境心脏病学这是一种炎症炎症炎症炎症.微塑料微塑料的使用纳米塑料是一种纳米塑料.氧化氧化是一种氧化.塑料污染 塑料污染更多相关视频
10:37Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
Published on: March 14, 2021
7.3K
08:22Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
Published on: September 15, 2018
8.6K
相关概念视频
01:30Coronary Artery Disease I: Introduction
869
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
869
01:26Atherosclerosis III: Management
312
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
312
01:26Coronary Artery Disease IV: Preventive Measures
580
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
580
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
531
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
531